GINKGOLIDE C

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C20H24O11
Molecular Weight	440.398
Optical Activity	UNSPECIFIED
Defined Stereocenters	12 / 12
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H][C@@]12OC(=O)[C@H](O)[C@@]13[C@@H]([C@@H](O)[C@H]4OC(=O)[C@]5(O2)[C@@]6(O)[C@H](C)C(=O)O[C@@]6([H])[C@H](O)[C@]345)C(C)(C)C

InChI

InChIKey=AMOGMTLMADGEOQ-DTDWCABLSA-N

InChI=1S/C20H24O11/c1-5-12(24)28-11-8(22)18-10-6(21)7(16(2,3)4)17(18)9(23)13(25)30-15(17)31-20(18,14(26)29-10)19(5,11)27/h5-11,15,21-23,27H,1-4H3/t5-,6-,7+,8+,9+,10-,11+,15+,17+,18-,19-,20-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C20H24O11
Molecular Weight	440.398
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	11 / 12
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15038029
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/26604665

Ginkgolide C (GC, BN52022), is a terpene lactone constituent of Ginkgo biloba, the ginkgo tree, is the oldest living tree, with a long history of use in traditional Chinese medicine. Ginkgolide C is 25-fold less potent than ginkgolide B as a platelet activating factor receptor antagonist, due to the presence of the 7beta-OH. Ginkgolide C may not be bioavailable at clinically relevant concentrations due to rapid metabolism.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Potency
platelet activating factor metabolic process 2 Target ID: GO:0046469 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2820421	Inhibitor 8297	37.6 µM [IC50]
GABA-A receptor; alpha-1/beta-2/gamma-2 27 Target ID: CHEMBL2095172 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15212966 \| https://www.ncbi.nlm.nih.gov/pubmed/26953225	Antagonist 2778	16.3 µM [Ki]
Platelet activating factor receptor 20 Target ID: CHEMBL250 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12570381 \| https://www.ncbi.nlm.nih.gov/pubmed/2850196	Antagonist 2778

Conditions

Condition	Modality	Targets	Highest Phase	Product
Stroke 144 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3432553	Primary		Basic research	Unknown Approved Use Unknown

PubMed

Title	Date	PubMed
Ginkgolide C inhibits platelet aggregation in cAMP- and cGMP-dependent manner by activating MMP-9.	2007 Dec	18057723

Patents

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Unknown

In Vitro Use Guide

Ginkgolide C was shown to inhibit in vitro platelet aggregation at 100 µM through stimulation of matrix-metalloproteinase-9

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:44:45 UTC 2023` Edited by `admin` on `Fri Dec 15 16:44:45 UTC 2023`
Record UNII	32ZQ957R4A
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

GINKGOLIDE C

Common Name

English

GINKGOLIDE C (CONSTITUENT OF GINKGO) [DSC]

Common Name

English

GINKGOLIDE C [MI]

Common Name

English

(1.ALPHA.,7.BETA.)-1,7-DIHYDROXYGINKGOLIDE A

Common Name

English

BN-52022

Code

English

9H-1,7A-(EPOXYMETHANO)-1H,6AH-CYCLOPENTA(C)FURO(2,3-B)FURO(3',2':3,4)CYCLOPENTA(1,2-D)FURAN-5,9,12(4H)-TRIONE, 3-(1,1-DIMETHYLETHYL)HEXAHYDRO-2,4,7B,11-TETRAHYDROXY-8-METHYL-, (1S,2R,3S,3AS,4R,6AR,7AR,7BR,8S,10AS,11R,11AR)-

Common Name

English

Ginkgolide C [WHO-DD]

Common Name

English

Code System Code Type Description

EPA CompTox

DTXSID60864569